Literature DB >> 7306990

Possible requirement of internalization in the mechanism of in vitro cytotoxicity in tumor necrosis serum.

F C Kull, P Cuatrecasas.   

Abstract

The mechanism of in vitro cytotoxicity by tumor necrosis serum (TNS) and a purified fraction was examined using sensitive L-M cells. Cell death was assessed by uptake of the dye trypan blue and/or by release of radiolabeled chromium. Cell killing was time and dose dependent. Cell survival was assessed by counting the number of survivors via their ability to internalize the dye neutral red and/or by adherent cell protein. The cytotoxin was not cytostatic. Survival was found to be inversely proportional to cell death. The change in survival was used to estimate the number of cells killed. The number of cells killed was logarithmically related to the amount of toxin. The ability to kill a fixed number of cells was inversely related to the number of cells in the assay well. It was estimated that, at ideal cell seed numbers, 1 microgram of TNS protein per 250 microliter killed about 50,000 cells in a 20-hr period. Sensitivity was equated with the amount of TNS required to kill 35,000 cells in 20 hr. Inhibitors of RNA and protein synthesis and also elevated temperatures enhanced sensitivity. The combined treatment of 1 microM actinomycin D and 40 degrees enhanced sensitivity by 15-fold. Resistant normal and tumorigenic cell lines (including human) were rendered sensitive by concomitantly treating them with TNS and cycloheximide or actinomycin D. Cytoskeletal-disrupting agents (colchicine, Colcemid, and cytochalasin B), inhibitors of lysosome activity (chloroquine, methylamine, and leupeptin), and 32 degrees all depressed sensitivity. Sensitivity was nearly equivalent in calcium-free medium. Results substituting partially purified cytotoxin were similar. The results suggest that a toxic factor(s) may need to be internalized and that lysosomal activity may be necessary for cell killing. Comparisons with lymphotoxin are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7306990

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Synergistic cytotoxicity of human recombinant tumour necrosis factor alpha combined with microtubule effectors.

Authors:  J Baumgart; B Schlott; J Suehnel; W Vater; W Schulze; D Behnke
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function.

Authors:  M Higuchi; B B Aggarwal; E T Yeh
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

3.  Signalling pathway of tumor necrosis factor in normal and tumor cells.

Authors:  N Watanabe; H Neda; Y Ohtusuka; H Sone; N Yamauchi; M Maeda; H Kuriyama; Y Niitsu
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Estimation of cell number by neutral red content. Applications for proliferative and survival assays.

Authors:  F C Kull; P Cuatrecasas
Journal:  Appl Biochem Biotechnol       Date:  1983-04       Impact factor: 2.926

5.  IL-1beta augments TNF-alpha-mediated inflammatory responses from lung epithelial cells.

Authors:  Sara Saperstein; Linlin Chen; David Oakes; Gloria Pryhuber; Jacob Finkelstein
Journal:  J Interferon Cytokine Res       Date:  2009-05       Impact factor: 2.607

6.  Comparison of cell deaths induced by transmembrane and secretory TNF-alpha.

Authors:  Lin Yang; Wenfang Shi; Jing Wang; Xiaodan Jiang; Wei Feng; Zuoya Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-04

7.  The different effects of recombinant human tumor necrosis factor on rat fibrosarcoma sublines.

Authors:  J Ishihara; N Saijo; Y Sasaki; H Nakano; A Ozaki; H Takahashi; M Sakurai; K Nakagawa; M Iigo; F Kanzawa
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

8.  Butylated hydroxyanisole inhibits tumor necrosis factor-induced cytotoxicity and arachidonic acid release.

Authors:  O L Brekke; T Espevik; K S Bjerve
Journal:  Lipids       Date:  1994-02       Impact factor: 1.880

9.  Macrophage-mediated cytotoxicity: role of a soluble macrophage cytotoxic factor similar to lymphotoxin and tumor necrosis factor.

Authors:  C M Zacharchuk; B E Drysdale; M M Mayer; H S Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

10.  Fibroblast growth factor increases TNF alpha-mediated prostaglandin E2 production and TNF alpha receptor expression in human fibroblasts.

Authors:  M Candela; S C Barker; L R Ballou
Journal:  Mol Cell Biochem       Date:  1993-03-10       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.